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Research
AbstrACt
Objectives To describe the type, frequency, seasonal and 
regional distribution of medication incidents in primary 
care in Switzerland and to elucidate possible risk factors 
for medication incidents.
Design Prospective surveillance study.
setting Swiss primary healthcare, Swiss Sentinel 
Surveillance Network.
Participants Patients with drug treatment who 
experienced any erroneous event related to the medication 
process and interfering with normal treatment course, as 
judged by their physician. The 180 physicians in the study 
were general practitioners or paediatricians participating in 
the Swiss Federal Sentinel reporting system in 2015.
Outcomes Primary: medication incidents; secondary: 
potential risk factors like age, gender, polymedication, 
morbidity, care-dependency, previous hospitalisation.
results The mean rates of detected medication incidents 
were 2.07 per general practitioner per year (46.5 per 
1 00 000 contacts) and 0.15 per paediatrician per year 
(2.8 per 1 00 000 contacts), respectively. The following 
factors were associated with medication incidents (OR, 
95% CI): higher age 1.004 per year (1.001; 1.006), care 
by community nurse 1.458 (1.025; 2.073) and care by an 
institution 1.802 (1.399; 2.323), chronic conditions 1.052 
(1.029; 1.075) per condition, medications 1.052 (1.030; 
1.074) per medication, as well as Thurgau Morbidity Index 
for stage 4: 1.292 (1.004; 1.662), stage 5: 1.420 (1.078; 
1.868) and stage 6: 1.680 (1.178; 2.396), respectively. 
Most cases were linked to an incorrect dosage for a given 
patient, while prescription of an erroneous medication was 
the second most common error.
Conclusions Medication incidents are common in adult 
primary care, whereas they rarely occur in paediatrics. 
Older and multimorbid patients are at a particularly high 
risk for medication incidents. Reasons for medication 
incidents are diverse but often seem to be linked to 
communication problems.
IntrODuCtIOn
Patient safety is a major concern in health-
care systems worldwide. Although most 
safety research has been conducted in the 
inpatient setting,1 evidence indicates that 
medical errors and adverse events pose a 
serious threat for patients in the primary care 
setting as well, since most patients receive 
ambulatory care.2–4 Information about the 
frequency and outcomes of safety incidents 
in primary care is required to identify risks 
or ‘hot spots’, to prioritise them and to take 
action as needed.5 The aim of the project was 
to describe the type, incidence, seasonal and 
regional distribution of medication incidents 
in primary care in Switzerland and to eluci-
date risk factors for medication incidents.
MethODs
Study design
We conducted a prospective surveillance 
study among primary care patients during 
2015 to identify cases of medication incidents.
study population
The study population was any person under-
going drug treatment in general internal 
or paediatric practises participating the 
Sentinella network. The latter covers a repre-
sentative sample of patients in primary care 
for Switzerland.5 Founded in 1986, it was 
mainly designed to survey transmissible 
diseases. Later, it also assessed other health 
problems of public interest. It generates daily 
to weekly current data and covers the entire 
strengths and limitations of this study
 ► This is the first prospective and systematic collection 
of incident data in primary care in Switzerland that 
is characterised by three linguistic regions and two 
drug distribution systems.
 ► It was conducted by experienced physicians and 
with high response rates.
 ► There is likely—as expected—bias from selective 
and under-reporting or non-detection of medication 
incidents.
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geographic and linguistic regions of our country. Chil-
dren, the mentally handicapped or the elderly were also 
included, all of whom might be at increased risk for medi-
cation errors.
Medication incidents
We defined medication incidents as any erroneous event 
(as defined by the physician) related to the medication 
process and interfering with normal treatment course 
(eg, administration of an erroneous medication). We did 
not include lack of treatment effect, adverse drug reac-
tions or drug-drug or drug-disease interactions without 
detectable treatment error. Nor did we consider medica-
tion incidents if patients refused to have them reported to 
the Sentinella system.
Data sources
The study physicians recorded the patient’s year of birth 
and gender on their weekly reporting form. After a 
maximum of 4 weeks, they had to fill in a detailed incident 
questionnaire (see online suplementary Appendix A). It 
comprised their Sentinella number and the calendar week 
of notification. Concerning the patients, they reported 
the living situation, several supposed risk factors for an 
incident as well as the following variables: hospitalisation 
during the previous year, care-dependency, number of 
drugs used chronically, number of chronic conditions 
and the Thurgau Morbidity Index (TMI, a seven-step 
Likert scale to measure morbidity in outpatients), to 
be compared with a denominator analysis (below). We 
further received a detailed description of the incident 
and proposals to avoid future incidents.
We got the annual number of patient-to-physician 
contacts (PPC) per practise from the Sentinella admin-
istration, as well as morbidity data from a fortnight 
cross-sectional denominator analysis of all patients 
consulting a Sentinella practice during weeks 11 or 
12 (Gnädinger M, Herzig L, Ceschi A et al. Chronic 
Conditions and Multimorbidity in the Swiss Primary Care 
Population - A Prospective Study in the Swiss Sentinel 
Surveillance Network. Sentinella. Submitted).
We received the anonymised list of participating physi-
cians, their specialty as well as the community size (Swiss 
Federal Statistical Office) and the linguistic region from 
the Sentinella administration. Information on Swiss medi-
cation sales in 2015 by the Anatomical Therapeutic 
Chemical (ATC) Classification System (an international 
classification for pharmaceutical products) was derived 
from Interpharma Switzerland (see online suplementary 
Appendix B).
The questionnaires were completed either electroni-
cally or on a paper/pencil version, the former as online 
SurveyMonkey questionnaires, the latter as sealed enve-
lopes sent from the Sentinella administration. We had 
three study questionnaires: a detailed incident ques-
tionnaire, an initial one and a final one. The detailed 
incident questionnaire collected information about the 
circumstances of the incident and about the patient’s 
properties (see online Supplementary Appendix A). The 
initial questionnaire served to describe the physician’s 
practices in terms of number of physicians, availability 
of electronic patient history, electronic drug-drug inter-
action control system and drug distribution system 
(see online Supplementary Appendix C). The final ques-
tionnaire investigated non-reporting and difficulties with 
coding the morbidity variables (see online Supplemen-
tary Appendix D).
We constructed a variable ‘incident relevance’ from the 
items ‘disturbance’ and ‘endangering’ of the patients; 
if any of them was graded with ‘medium’ or higher, the 
variable relevance was set to ‘more’, otherwise it was set 
to ‘less’. Because of question ambiguity, we set coding 
of the item care-dependency to ‘missing’ for patients 
younger than 20 years of age. Evans’ Index—a prognostic 
index—was calculated by simple addition of the number 
of chronic drug treatments with the number of chronic 
conditions.6
The following free text variables were manually coded: 
relationship of the incident to the suspected medication, 
preventability of the incident, reactions to the incident 
and proposals to avoid further incidents.
statistical methods
Values are given as frequencies, mean±SD or median 
(IQR) (as denoted with first quartile; forth quartile), 
depending on non-normal distribution or non-interval 
scaled data level. To assess the association of medica-
tion incidents with potential risk factors, we used the 
SPSS-GENLINMIXED procedure (a procedure that 
fits generalised linear mixed models). Clustering of 
patients was addressed by using a mixed binary logistic 
regression with the fixed factors of gender, year of birth, 
care-dependency, number of chronic drug treatments, 
number of chronic conditions and TMI as well as the 
physicians’ practice number as a random factor; if one 
item was missing, the whole record was excluded from 
the analysis. Numerator was affiliation to the case group; 
denominator was all PPC during weeks 11 and 12. We 
used IBM SPSS V.23.
results
The Sentinella system
During the year 2015, 149 practices were enrolled to the 
Sentinella system. Of them, 144 practices were known to 
report regularly; their properties are listed in table 1. The 
Sentinella physicians are representative for the overall Swiss 
physician population.5 Drugs were autodistributed by 42% 
of the study practices. Approximately half of the physi-
cians had electronic and the other paper-based medical 
records. Systematic drug-drug interaction control systems 
were installed only by a minority (36.8%) of the physi-
cians. During the year 2015 (which included unusually for 
calendar adaptation, 53 instead of 52 reporting weeks), 
the general practitioners (GPs) had 4456±2137 PPC; 
for the paediatricians (PEDs), these were 5297±2715 
(mean±SD). In their initial study questionnaire, 25.0% of 
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the reporting physicians admitted to be working part time 
(ie, <30 hours per week).
study flow
During the year 2015, we received 216 incident notifica-
tions (figure 1). In 11 cases, we did not receive the detailed 
notification form. Eight cases had to be removed from the 
database because they fulfilled the exclusion criterion (ie, 
‘adverse drug reactions without detectable error’), and 
one case had to be removed because of double data entry. 
This led to 197 cases which could be analysed. The distri-
bution of the monthly incident notifications throughout 
2015 is depicted in online Supplementary Figure e1, 
Appendix E), and the distribution of the numbers of 
cases reported by each practice in figure 2.
Description of patients
Table 2 lists age, gender and geographic distribution 
as well as the physician-to-patient relationship and the 
observer of the incident. Only three cases evolved in 
PED practices. No statistically significant differences were 
found between the two relevance classes of the incidents.
number of incidents, non-reporting
In the GPs 194 incidents, 148 physicians, 4456 yearly PPC 
led to 1.31 incidents per physician per year or 29.4 per 
1 00 000 PPC; in PEDs 3 incidents, 32 physicians, 5297 
yearly PPC led to 0.1 incident per physician per year or 
1.8 per 1 00 000 PPC.
To evaluate the non-reporting of incidents, we asked 
the physicians in the final study questionnaire. Out 
of 180 actively reporting physicians, we received 145 
Table 1 Characteristics of the reporting physicians in 2015
Physicians’ gender
  Male
  Female
128 (71.1%)
52 (28.9%)
Physicians’ age class (years)
  <40
  40–49
  50–59
  60 and over
12 (6.7%)  
44 (24.4%)
66 (36.7%)
58 (32.2%)
Specialty
  GP
  PED
148 (82.2%)
32 (17.8%)
Number of physicians in practice (n=144)
  1
  2
  3
  4–5
  6–9
  10 and over
69 (47.8%)
39 (27.1%)
17 (11.8%)
8 (5.6%)
7 (4.9%)
4 (2.8%)
Number of physicians per practice reporting to Sentinella 
(n=144)
  1
  2
  3
  8
119 (82.6%)
19 (13.2%)
5 (3.5%)
1 (0.7%)
Linguistic region
  German
  French
  Italian
122 (67.8%)
44 (24.4%)
14 (7.8%)
Urbanity of the practice
  Urban
  Agglomeration
  Rural
93 (51.7%)
60 (33.3%)
27 (15.0%)
Workload per week (hours)
  <15
  15–30
  >30
9 (5.0%)
36 (20.0%)
135 (75.0%)
Drug distribution system
  Dispensing by physician
  Mixed system
  Dispensing by pharmacy
73 (42.2%)
19 (10.6%)
85 (47.2%)
Electronic documentation
  Yes
  No
89 (49.4%)
91 (50.6%)
Electronic interaction control
  Yes
  No
65 (36.1%)
115 (63.9%)
Electronic prescription
  Yes, with thesaurus
  Yes, but without thesaurus
  None
62 (34.4%)
24 (13.3%)
94 (52.2%)
Certification of the practice
  Yes
  None
46 (25.6%)
134 (74.4%)
Continued
Staff meetings
  Yes, at least monthly
  Yes, but less frequently
  None
69 (38.3%)
70 (38.9%)
41 (22.8%)
Quality circle participation
  Yes, at least monthly
  Yes, but less frequently
  None
134 (74.4%)
23 (12.8%)
23 (12.8%)
Table 1 Continued 
Figure 1 Study flow chart.
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questionnaires (80.6% response rate). To our question: 
‘Did you not report medication incidents that you had 
noticed during the last year?’, they answered: ‘Never 
or almost’ 110 (75.9%), ‘yes, but seldom’ 22 (15.2%), 
‘yes, frequently’ 9 (6.2%), ‘always, or almost’ 4 (2.8%). 
Reasons for not reporting incidents were ‘lack of time’ or 
‘forgetfulness’. If we speculate that these answers repre-
sent reporting rates of 76%–100%, 51%–75%, 26%–50% 
or 0%–25%, respectively, we could divide the observed 
rates by the middle of the reporting classes: 0.875, 0.625, 
0.375 and 0.125. By doing so, we calculated a rate of 50% 
of under-reporting; if we furthermore consider the 5% 
of the incidents where the questionnaires were not sent, 
this rate increases to 58%. We therefore have to multiply 
the observed rates with a factor of 1.58 resulting in the 
following rates of detected incidents: GP 2.07 per physi-
cian per year, 46.5 per 1 00 000 PPC and PED 0.15 per 
physician per year, 2.8 per 1 00 000 PPC.
types and causes of incidents, organ systems involved, 
preventability
The types of error are listed in  online Supplementary table 
e1, Appendix E and figure 3; in 26 cases, more than one 
was mentioned. Most cases were linked to an incorrect 
dosage for a given patient, while prescription of an erro-
neous medication was the second most common error.
Most errors concerned orally ingested medication. 
Errors in application of parenteral drugs were reported 
less frequently; in our study, they comprised insulin (one 
case) and vaccinations (three cases). There were cases 
of an incorrect (influenza vs antitetanus) or incomplete 
(Boostrix vs Boostrix-Polio) vaccination and of undue 
vaccination (a third anti-HPV vaccine). One case was due 
to a communication problem within the practice staff, 
another to a vaccination in absence of the vaccination 
card.
Three cases concerned paediatric patients, all were 
linked to inadequate dosing, two times of an antibiotic 
prescription (cotrimoxazole, co-amoxicillin) and one 
time of an antiemetic drug (thiethylperazine).
In 89 of the 195 cases, organ system damage was reported, 
in 13 cases more than one organ system was involved, most 
frequently the central nervous system (figure 4) (see also 
the online Supplementary table e2, Appendix E). Possible 
triggers of the incident were reported in 194 of the 197 
cases; in 45 cases, there was more than one single reason, 
most frequently lacking alertness of the reporting physi-
cians or their staff (see online Supplementary table e3, 
Appendix E). When asked, who might be the ‘responsible’ 
for the incident, 191 replied. The most common person 
or institution possibly responsible for the medication inci-
dent was: the reporting physician 41 (21.5%), followed 
by the practice nurse 26 (13.6%), the institution where 
the patient lives 33 (17.3%), the pharmacy 7 (3.7%), the 
hospital 12 (6.3%), the community nurse 4 (2.1%), the 
patients or their proxies 15 (7.9%) and the manufac-
turer 2 (1.0%); in 9 cases (4.6%) this was unclear, in 37 
cases (19.4%), there was more than source one to blame. 
Preventability of the incidents was classified (by our study 
board): unlikely in 6 cases (3.0%), possible in 58 (29.4%), 
probable in 114 (57.9%) and definite in 19 (9.6%).
Figure 2 Distribution of the number of cases reported by practice.
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endangering and disturbances
In 192 of the 197 cases, the item ‘patients’ endangering’ 
as estimated by the physicians was answered. In 39 cases 
(20.3%), there was no endangering, in 83 (43.2%) light, 
in 51 (26.6%) moderate, in 19 (9.9%) severe. The answers 
to item ‘disturbances caused by the incident’ are listed in 
table 3. Out of the 197 incidents, 74 (37.5%) were clas-
sified as ‘more’ relevant (see the 'Methods' section and 
table 2).
Interface problems, orientation, predictability, repeat incidents
The presence of interface problems was reported in 64 of 
197 cases (32.4%); these were with a hospital in 28 cases 
(43.8%), with an institution in 14 (21.9%), with a commu-
nity nurse in 6 (9.4%), with a pharmacist in 9 (14.0%), 
with a specialist in 3 (4.7%) and with others in 4 (6.3%). 
In 184 cases, we received information about informing 
patients about the incident; in 98 cases, the patient was 
oriented by the reporting physician or his staff (50.3%), 
non-orientation was stated: because the patient was not 
able to understand (children, demented) in 26 cases 
(14.1%), because the problem had already been solved 
and the notification would have unduly disturbed the 
confidence in 18 cases (9.8%), because the patient or the 
proxies had observed it themselves in 23 cases (12.5%), 
because the patient had already been oriented by others 
in 7 cases (3.8%) or because of another reason in 12 cases 
(6.5%). As for predictability of the incident, we received 183 
valid answers; of them 82 (44.8%) stated ‘yes, in the given 
constellation, the incident was to be expected’. When 
asked whether they had already reported a similar incident 
in the study, 29 out of 196 (14.8%) answered in the affir-
mative.
risk factors to undergo a medication incident
To detect patient risk factors to undergo an incident, we 
compared the incident data with those of a fortnight 
denominator analysis; the following univariate factors 
accumulated preferentially in incident patients: higher 
age, care-dependency, higher numbers of chronic condi-
tions or medications (or higher Evans’ Index) as well as 
higher TMI (table 4). In the logistic regression, only inpa-
tient care by an institution remained a significant factor. 
Other suspected risk factors are listed in online Supple-
mentary table e4, Appendix E); these items were not 
included in the denominator study and therefore lack 
a comparator. Within the patient group with a more as 
compared with a less relevant incident, only psychiatric 
illness reached a significantly increased proportion. We 
did not detect major differences between the two drug 
distribution systems.
Table 2 General description of the cases
Relevance
AllLess More
Number of cases 124 73 197
Patient’s age 69.2±20.6 69.4±21.2 69.3±20.8
Patient’s gender, % males 40.3 32.9 37.6
Physician’s specialty % paediatricians 1.6 1.4 1.5
Linguistic region, %
  German 75.0 68.5 72.6
  French 18.5 28.8 22.3
  Italian 6.5 2.7 5.1
Physician-to-patient relationship, %
  Own family physician 86.3 78.1 83.2
  Urgency / holiday replacing 0.8 4.1 2.0
  Institution physician 11.3 17.8 13.7
  Other 1.6 0.0 1.0
Observer of the incident; % 
  Physician/practisepractice staff 50.0 50.7 50.3
  Patient / proxies 21.8 23.3 22.3
  Community nurse 1.6 4.1 2.5
  Institution (where patient lives) 15.3 16.4 15.7
  Hospital 0.8 1.4 1.0
  Other physicians 2.4 0.0 1.5
  Pharmacist 7.3 4.1 6.1
  Other 0.8 0.0 0.5
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Figure 3 Type of error.
Figure 4 Organ system involved.
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relationship between incidents and drug class, AtC group
We assessed semi-quantitatively whether the class of the 
suspected drug was causally linked to the emergence of 
the incident; the frequencies were: none 49 (25.1%), 
unlikely 31 (15.9%), possible 77 (39.5%), probable 34 
(17.4%), definite 4 (2.1%), did not apply 2 (not avail-
able). ATC codes of the suspected medications are 
listed in table 5. Most naming concerned the groups C 
‘cardiovascular’ (23.2%) and N ‘nervous system’ (22.1%). 
Among the medication classes judged to be related to the 
incident (n=38), the most frequently named groups were 
oral anticoagulants: rivaroxaban 9, phenprocoumon 7 
and acenocoumarol 2 cases; this explains the seven fold 
increased relative risk of ATC group B as compared with 
sales. As an example for errors without relation to the 
drug class, we must mention the 17 cases of institution-
alised patients ingesting medications scheduled for other 
residents, in most cases this was a person eating at the 
same table, but in other cases the person in care mixed 
up patient names.
reactions to the incident and suggestions to prevent further 
ones
In 141 of the 197 cases, the physicians reported to have 
changed something after the incident, in 13 cases this 
was more than one single action, mostly often named were 
communication with other caregivers or better instruction 
of patients (see online Supplementary table e5, Appendix 
E). The respondents were asked for proposals how to 
prevent future incidents of the reported type; 125 of them 
made a total of 243 suggestions (see online Supplemen-
tary table e6, Appendix E). Of these, 37 (15.2%) were 
related to accurate medication lists, 10 (4.1%) to better 
patient instructions, 38 (15.6%) to organisation of regular 
follow-up controls and 55 (22.6%) involved organisa-
tional changes within the practice and its staff.
DIsCussIOn
In a representative group of primary care physicians,7 we 
found approximately one case of a medication incident 
per GP and year.
Incident rates
Incident rates in this study were similar to those found in 
other studies. We calculated the rates of detected medi-
cation incidents as follows: GP 2.07 per physician and 
year, 46.5 per 1 00 000 PPC and PED 0.15 per physician 
and year, 2.8 per 1 00 000 PPC. Medication incidents may 
make up a proportion of approximately one-third of all 
incidents8; the rates for all safety incidents may amount 
6.20 per physician and year or 139.4 per 1 00 000 PPC in 
GPs and 0.45 per physician and year or 8.4 per 1 00 000 
PPC in PEDs.
In Australian primary care patients, an incident rate of 
4.98 per GP and year was reported; this is close to our esti-
mated rate of 6.20; however, there was no subtyping of the 
incidents.9 In a 3-year study, O’Beirne et al reported a rate 
of 1.8 safety incidents per year and physician.8 In a liter-
ature review of western countries’ publications, Sandars 
and Esmail described a rate of 5 to 80 errors per 1 00 000 
consultations,2 a rate somewhat lower than the 139.4 cases 
per 1 00 000 consultations estimated in our study. Kuo 
et al reported a proportion of 15% of all incidents to be 
related to medication10 ; since we estimated a proportion 
of 33% would give rise to even higher rates of all safety 
incidents when calculated from our study database. An 
Table 3 Disturbances after the incident
Item N Per cent
Severity of disturbance
  No symptoms but pathological 
laboratory tests
15 8.0
  Light 44 23.4
  Moderate 22 11.7
  Severe 10 5.3
  Fatality 0 0.0
Subtotal (this is the base of the next 
rows)
91 48.4
  No symptoms, normal (or no) 
laboratory tests
97 51.6
Total 188 100.0
Missing data 9 n.a.
All patients 197 n.a.
Time until recovery
  Hours 26 28.5
  Days 41 45.1
  Weeks 15 16.5
  Not yet known or missing information 9 9.9
All patients with disturbances 91 100.0
Recovering
  Without sequels 78 85.8
  With light-to-moderate sequels 2 2.2
  With severe sequels or fatality* 5 5.4
  Not yet known or missing information 6 6.6
All patients with disturbances 91 100.0
Treatment / surveillance
  Not needed 48 52.7
  Ambulatory care 33 36.3
  Hospital care** 7 7.7
  Missing information 3 3.3
All patients with disturbances 91 100.0
* In one case, there was a reduced kidney function, the other cases 
remained unclear, and no fatalities were reported. 
** Two cases had to be surveilled in the emergency room, the 
hospital stays were: intoxications with thiethylperazine, with 
fenoterol plus ipratropium bromide, with zolpidem, further a 
derailed diabetes type 2 (after missed treatment with metformin), 
and a gastrointestinal haemorrhage in a patient where 
antithrombotic treatment with rivaroxaban was not communicated 
to the physician.
n.a., not available.
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11% group of the physicians worked part time, the rate 
per full-time physician per year may therefore be some-
what higher than calculated. The 13-fold higher incident 
rate in GPs as compared with PEDs is not surprising given 
the lower medication rates in children. A recent British 
study confirmed this much lower rate of incidents in chil-
dren; out of 46 902 family practice safety reports, 1788 
concerned children (26-times less than adults).11
Definition of incidents and reliability of reporting
On the other hand, incident rates may be influenced 
by their definition. Gandhi et al coined the term ‘avoid-
able adverse drug reaction’.12 In our study, we explicitly 
excluded adverse drug reactions without detectable error. 
Runciman et al defined a patient safety incident as follows: 
‘An event or a circumstance that could have resulted or 
did result in unnecessary harm to a patient’.13 An intuitive 
definition of a medical error was given by Makeham et al: 
"That was a threat to patient wellbeing and should not 
happen. I don’t want it to happen again".14 As shown in 
online  Supplementary figure e1, Appendix E), reporting 
frequency was higher at the beginning of the study as 
compared with the later course of it. This could reflect 
some loss of interest or forgetfulness by the reporting 
physicians. As calculated from our final questionnaire 
after the study, the reporting physicians failed to report 
about one in three cases of the detected medication 
errors. Non-detection of incidents may even be more 
frequent than non-reporting of observed incidents. A 
missed possible drug-drug interaction may be detected 
by chart review, a documentation error would probably 
have been found only in 1:1 supervision, which is very 
time-consuming, costly and may additionally influence 
performance of the observed physician. It is therefore 
virtually impossible to decipher the real rate of non-de-
tected incidents. The problems in detection of incidents 
were the reason to postulate a ‘mix of methods’ as needed 
to identify adverse events in general practice.15
Other approaches to investigate safety incidents
In contrast to our prospective investigation, there 
are other methods to approach safety incidents. In 
a retrospective, semi-quantitative analysis, Gehring 
et al investigated safety incidents in Swiss primary 
Table 5  ACT groups of suspected medications
ATC class All incidents
Incidents with 
probable or definite 
relationship with 
medication
Relative risk
(percentages left 
by right column)
Swiss 2015 sales* 
(number of packages)
A Alimentary tract and metabolism 28 (14.6%) 6 (15.8%) 1.06 31 455 252 (14.9%)
B Blood and blood-forming organs 23 (12.0%) 7 (18.4%) 7.08 5 507 624 (2.6%)
C Cardiovascular system 44 (22.9%) 1 (2.6%) 0.35 16 027 143 (7.5%)
D Dermatologics 1 (0.5%) 0 (0.0%) 0.00 17 314 810 (8.2%)
G Genitourinary system and sex 
hormones
1 (0.5%) 0 (0.0%) 0.00 7 936 641 (3.7%)
H Systemic hormonal preparations 
(excluding sex hormones and 
insulins)
7 (3.6%) 1 (2.6%) 2.00 2 875 760 (1.3%)
J Anti-infectives for systemic use 23 (12.0%) 6 (15.8%) 3.95 8 444 623 (4.0%)
K Infusion liquids 0 (0.0%) 0 (0.0%) 0.00 24 158 749 (11.5%)
L Antineoplastic and 
immunomodulating agents
5 (2.6%) 1 (2.6%) 2.89 1 934 950 (0.9%)
M Musculoskeletal system 4 (2.1%) 2 (5.3%) 0.76 14 787 413 (7.0%)
N Nervous system 43 (22.4%) 10 (26.3%) 1.30 42 690 195 (20.2%)
P Antiparasitic products, 
insecticides and repellents
1 (0.5%) 0 (0.0%) 0.00 4 62 559 (0.2%)
R Respiratory system 7 (3.6%) 3 (7.9%) 0.57 28 837 468 (13.7%)
S Sensory organs 2 (1.0%) 0 (0.0%) 0.00 7 658 311 (3.6%)
T Diagnostic use 0 (0.0%) 0 (0.0%) 0.00 43 184 (0.0%)
V Various 3 (1.6%) 1 (2.6%) 6.50 8 55 707 (0.4%)
Total 192 (100.0%) 38 (100%) 1.0 210 990 389 (100.0%)
Does not apply 5 0 n.a. n.a.
* Information by Interpharma Switzerland (see online Supplementary Appendix B).
Relative risk of drugs with probable or definite relationship with the incident as compared with sales proportions. 
n.a., not available.
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care16; among 23 predefined classes of safety incidents, 
the respondents admitted 15 to have occurred at least 
yearly—four of them being linked to drug treatment. 
Another approach to incidents is to ask patients as 
performed by Mira et al17; they interviewed patients 
(>65 years with five or more chronic drug treatments) 
and found that 75% of the patients reported to have 
been affected by at least one medication error during 
the previous 12months. We did not collect data on 
appropriateness of treatment; admittedly medication 
inappropriate for some groups of patients (elderly or 
patients with impaired renal function) may provoke 
incidents.18 A recent Scottish study demonstrated 
an impressive reduction in high-risk prescriptions 
(non-steroidal anti-inflammatory drugs, antiplatelet 
and anticoagulation) as well as hospital admissions 
for gastrointestinal ulcers or heart failure by a combi-
nation of educational measures, informatics and 
financial incentives.19
type, consequences, causes and preventability of error
Most cases in this study involved application of an 
erroneous dosing or of a wrong medication, although 
non-application of necessary medication was also 
frequent. The distribution of the incidents was similar 
to that reported in other studies.10 16 17 20 When a 
wrong medication was dispensed, the error was often 
caused by confounding of prepared medication in 
home residents. The classic case of non-application 
of a necessary medication was the missed reuptake 
of anticoagulation after an operation. Non-applica-
tion of necessary drugs seems to be a relevant source 
of unnecessary harm to patients.21 The causing of the 
incidents was similar as reported by others.10 16 17 20 
Most studies found—as in our patients—lacking alert-
ness of and communication problems within practice 
staff, but there was a large variety of other topics. All 
three paediatric cases were linked to prescription of an 
inadequate dosing for age and weight. More than half 
of the patients did not have any disturbances after the 
incident; otherwise in most cases, the nervous system 
was affected. No fatalities were reported, but seven 
patients (3.5%) needed stationary care. In 2004, Piro-
hamed et al published a study on adverse drug reactions 
as a cause for admission to hospital; they found that 
6.5% of all hospitalisations and 4.0% of all hospital 
days were caused by adverse drug reactions, 72% of 
them being preventable and 2% leading to death22; 
however, this study included all cases, and therefore 
a majority of cases of adverse drug reactions without a 
detectable error. An older Swiss study was published 
by Livio et al; out of 3195 hospitalisations, she identi-
fied 229 cases (7.2%) as probably caused by adverse 
drug reactions.23 In that study, 32% of the events were 
classified as being preventable (which does not strictly 
mean that an error had caused the incident), and in 
6% of the cases, fatalities were reported. The results 
on outpatients contrast to inpatients where 1 in 10 
drug administrations was described to be erroneous.24 
Medical errors seem to be the third leading cause of 
death in the USA.25
risk factors
We were able to identify some risk factors such as higher 
age, care-dependency, higher numbers of chronic condi-
tions or medications (and higher Evans’ Index) as well as 
higher TMI. However, adjusted in the logistic regression 
analysis, only care-dependency remained a significant risk 
factor, but this may be due to the small number of obser-
vations, which possibly precluded less important risk 
factors to be detected. The only significant risk factor for 
undergoing an incident of higher relevance was psychi-
atric disease. Several factors which reflect quite well the 
results of our study have been described in the literature 
to correlate with proneness to undergo a medication 
incident: mainly the number of drugs ingested,12 26 but 
also higher or young age27 and morbidity28 29 have been 
described. Most incidents concerned ATC groups N 
‘nervous system’ or C ‘cardiovascular’, which were also 
of the mostly sold drugs; an exception was group B with 
anticoagulants and a sevenfold increased relative risk 
as compared with Swiss sales in 2015. It seems wise to 
be alert to avoid errors when prescribing medication of 
these groups. The prevailing position of anticoagulants 
(18.5% of cases) was described also by Field et al.29 Other-
wise, the repartition of our suspected drugs was similar to 
other primary care studies,10 29 a literature review30 or a 
theoretical paper.20
limitations
There is likely as expected bias from selective and 
under-reporting or non-detection of medication inci-
dents. Therefore, the true rate of incidents could only 
be estimated, and the proportions of incident charac-
teristics would probably substantially have been altered 
by a more complete recording of incidents.
COnClusIOn
Medication incidents are common in general medicine, 
whereas they rarely occur in paediatrics, in which polyphar-
macy is less prevalent. Reasons for medication incidents 
are diverse but often seem to be linked to communication 
problems. Older and multimorbid patients are at a partic-
ularly high risk for medication incidents.
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